Clinical Trial Update: A Safety and Effectiveness Study of Vaccine Therapy in Patients With Indolent Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 safety and effectiveness study of a vaccine therapy in indolent lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma Follicular
• Lymphoma Small Lymphocytic

Snippet

Sponsor: Agenus Inc. | Conditions: Lymphoma, Follicular, Lymphoma, Small Lymphocytic | Phase 2 | Status: COMPLETED